Cubist Systematic Strategies’s Cellectis CLLS Stock Holding History

Cubist Systematic Strategies’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,859	Closed	-$13.5K	–	3039
2025 Q1	$13.5K	Buy	+10,859	New	+$16.1K	﹤0.01%	2758
2020 Q1	–	Sell	-2,058	Closed	-$35K	–	2201
2019 Q4	$35K	Sell	2,058 -1,549	-43%	-$20.7K	﹤0.01%	2305
2019 Q3	$38K	Sell	3,607 -2,994	-45%	-$40.3K	﹤0.01%	2082
2019 Q2	$103K	Buy	+6,601	New	+$118K	﹤0.01%	2227
2018 Q4	–	Sell	-1,714	Closed	-$48K	–	2083
2018 Q3	$48K	Buy	+1,714	New	+$49.2K	﹤0.01%	1711
2018 Q2	–	Sell	-948	Closed	-$30K	–	1821
2018 Q1	$30K	Buy	+948	New	+$29.9K	﹤0.01%	1734
2015 Q2	–	Sell	-600	Closed	-$21K	–	1842
2015 Q1	$21K	Buy	+600	New	+$21.8K	﹤0.01%	1820

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cubist Systematic Strategies's CLLS Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Cellectis (CLLS) in Q2 2025, closing a stake of 10,859 shares — an estimated $13.5K sold.

Cubist Systematic Strategies first reported a position in CLLS in Q1 2015 and held it in 7 quarters. The position peaked at $103K in Q2 2019. 24 funds tracked by Wall St. Rank hold CLLS as of Q2 2025.

Cubist Systematic Strategies reported no remaining Cellectis position as of Q2 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 10,859 Cellectis shares in Q2 2025, an estimated $13.5K.
Cubist Systematic Strategies first reported a position in Cellectis in Q1 2015 and held it in 7 quarters.
Cubist Systematic Strategies's Cellectis position peaked at $103K in Q2 2019.
24 funds tracked by Wall St. Rank held Cellectis as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.